Clinical Trial ID: NCT05095376
A Phase III Trial of Gleostine® (Lomustine)-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients With Methylated MGMT Promoter Glioblastoma
Status
Open
Conditions
Brain and Nervous System
Phases
III
Age Group
Adult
Main Investiagtor
Cavaliere, Robert
Practice
CNS
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT05095376
Keywords
Treatment